Literature DB >> 27038492

Hyperthyroidism.

Simone De Leo1, Sun Y Lee1, Lewis E Braverman1.   

Abstract

Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves' disease, followed by toxic nodular goitre. Other important causes of thyrotoxicosis include thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess thyroid hormones. Treatment options for Graves' disease include antithyroid drugs, radioactive iodine therapy, and surgery, whereas antithyroid drugs are not generally used long term in toxic nodular goitre, because of the high relapse rate of thyrotoxicosis after discontinuation. β blockers are used in symptomatic thyrotoxicosis, and might be the only treatment needed for thyrotoxicosis not caused by excessive production and release of the thyroid hormones. Thyroid storm and hyperthyroidism in pregnancy and during the post-partum period are special circumstances that need careful assessment and treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27038492      PMCID: PMC5014602          DOI: 10.1016/S0140-6736(16)00278-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  139 in total

Review 1.  Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis.

Authors:  A de Rooij; J P Vandenbroucke; J W A Smit; M P M Stokkel; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2009-08-11       Impact factor: 6.664

2.  New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research.

Authors:  Elizabeth N Pearce; James V Hennessey; Michael T McDermott
Journal:  Thyroid       Date:  2011-06       Impact factor: 6.568

Review 3.  The thyrotropin receptor in thyroid diseases.

Authors:  R Paschke; M Ludgate
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

Review 4.  Life-threatening thyrotoxicosis. Thyroid storm.

Authors:  H B Burch; L Wartofsky
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

Review 5.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

6.  Hepatotoxicity and cutaneous reactions after antithyroid drug administration.

Authors:  Fumiko Otsuka; Jaeduk Y Noh; Toshiko Chino; Taeko Shimizu; Koji Mukasa; Kunihiko Ito; Koichi Ito; Matsuo Taniyama
Journal:  Clin Endocrinol (Oxf)       Date:  2012-08       Impact factor: 3.478

Review 7.  The interrelationships between thyroid dysfunction and hypogonadism in men and boys.

Authors:  A Wayne Meikle
Journal:  Thyroid       Date:  2004       Impact factor: 6.568

8.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

9.  Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.

Authors:  K Boelaert; A A Syed; N Manji; M C Sheppard; R L Holder; S C Gough; J A Franklyn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-05-06       Impact factor: 3.478

Review 10.  Diagnosis and management of thyrotoxicosis.

Authors:  Bijay Vaidya; Simon H S Pearce
Journal:  BMJ       Date:  2014-08-21
View more
  138 in total

1.  Dome-and-dart T Waves and Hyperthyroidism - A Case Report.

Authors:  Matteo Parolin; Francesca Dassie; Eugenio De Carlo; Roberto Vettor; Pietro Maffei
Journal:  Eur Endocrinol       Date:  2020-02-28

2.  Primary Microcephaly with Novel Variant of MCPH1 Gene in Twins: Both Manifesting in Childhood at the Same Time with Hashimoto's Thyroiditis.

Authors:  Piero Pavone; Xena Giada Pappalardo; Andrea Domenico Praticò; Agata Polizzi; Martino Ruggieri; Maria Piccione; Giovanni Corsello; Raffaele Falsaperla
Journal:  J Pediatr Genet       Date:  2020-04-23

3.  Pesticide use and incident hyperthyroidism in farmers in the Agricultural Health Study.

Authors:  Srishti Shrestha; Christine G Parks; Whitney S Goldner; Freya Kamel; David M Umbach; Mary H Ward; Catherine C Lerro; Stella Koutros; Jonathan N Hofmann; Laura E Beane Freeman; Dale P Sandler
Journal:  Occup Environ Med       Date:  2019-02-25       Impact factor: 4.402

4.  GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.

Authors:  Hong Soon Kang; Dhirendra Kumar; Grace Liao; Kristin Lichti-Kaiser; Kevin Gerrish; Xiao-Hui Liao; Samuel Refetoff; Raja Jothi; Anton M Jetten
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 5.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 2, Systemic Miscellaneous Conditions.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

6.  Changes in bone mineral density, 25-hydroxyvitamin D3 and inflammatory factors in patients with hyperthyroidism.

Authors:  Yali Zhou; Xixia Wang; Maoyuan Xin; Haiting Zhuang
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

7.  Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Authors:  Peter D Inskip; Lene H S Veiga; Alina V Brenner; Alice J Sigurdson; Evgenia Ostroumova; Eric J Chow; Marilyn Stovall; Susan A Smith; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Charles A Sklar; Jay H Lubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-12       Impact factor: 7.038

Review 8.  Preoperative management in patients with Graves' disease.

Authors:  Eliana Piantanida
Journal:  Gland Surg       Date:  2017-10

9.  Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves' disease.

Authors:  Brian Hung-Hin Lang; Yu-Cho Woo; Keith Wan-Hang Chiu
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

10.  Does Surgery Without Lugol's Solution Pretreatment for Graves' Disease Increase Surgical Morbidity?

Authors:  Frederic Mercier; Mathieu Bonal; Florian Fanget; Laure Maillard; Nathalie Laplace; Jean-Louis Peix; Jean-Christophe Lifante
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.